174 related articles for article (PubMed ID: 15520823)
1. Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies.
Crough T; Purdie DM; Okai M; Maksoud A; Nieda M; Nicol AJ
Br J Cancer; 2004 Nov; 91(11):1880-6. PubMed ID: 15520823
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor modulates alpha-galactosylceramide-responsive human Valpha24+Vbeta11+NKT cells.
Crough T; Nieda M; Nicol AJ
J Immunol; 2004 Oct; 173(8):4960-6. PubMed ID: 15470038
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
Kikuchi A; Nieda M; Schmidt C; Koezuka Y; Ishihara S; Ishikawa Y; Tadokoro K; Durrant S; Boyd A; Juji T; Nicol A
Br J Cancer; 2001 Sep; 85(5):741-6. PubMed ID: 11531261
[TBL] [Abstract][Full Text] [Related]
5. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
van der Vliet HJ; Molling JW; Nishi N; Masterson AJ; Kölgen W; Porcelli SA; van den Eertwegh AJ; von Blomberg BM; Pinedo HM; Giaccone G; Scheper RJ
Cancer Res; 2003 Jul; 63(14):4101-6. PubMed ID: 12874013
[TBL] [Abstract][Full Text] [Related]
6. Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells.
Okai M; Nieda M; Tazbirkova A; Horley D; Kikuchi A; Durrant S; Takahashi T; Boyd A; Abraham R; Yagita H; Juji T; Nicol A
Vox Sang; 2002 Oct; 83(3):250-3. PubMed ID: 12366768
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.
Molling JW; Kölgen W; van der Vliet HJ; Boomsma MF; Kruizenga H; Smorenburg CH; Molenkamp BG; Langendijk JA; Leemans CR; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
Int J Cancer; 2005 Aug; 116(1):87-93. PubMed ID: 15756674
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.
Nieda M; Okai M; Tazbirkova A; Lin H; Yamaura A; Ide K; Abraham R; Juji T; Macfarlane DJ; Nicol AJ
Blood; 2004 Jan; 103(2):383-9. PubMed ID: 14512316
[TBL] [Abstract][Full Text] [Related]
10. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
Huang Y; Jiang EL; Zhou Z; He Y; Wang M; Liu QG; Zhai WJ; Han MZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):315-20. PubMed ID: 16038267
[TBL] [Abstract][Full Text] [Related]
11. Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.
Harada Y; Imataki O; Heike Y; Kawai H; Shimosaka A; Mori S; Kami M; Tanosaki R; Ikarashi Y; Iizuka A; Yoshida M; Wakasugi H; Saito S; Takaue Y; Takei M; Kakizoe T
J Immunother; 2005; 28(4):314-21. PubMed ID: 16000949
[TBL] [Abstract][Full Text] [Related]
12. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.
van der Vliet HJ; von Blomberg BM; Hazenberg MD; Nishi N; Otto SA; van Benthem BH; Prins M; Claessen FA; van den Eertwegh AJ; Giaccone G; Miedema F; Scheper RJ; Pinedo HM
J Immunol; 2002 Feb; 168(3):1490-5. PubMed ID: 11801694
[TBL] [Abstract][Full Text] [Related]
13. Efficient ex vivo expansion of Valpha24+ NKT cells derived from G-CSF-mobilized blood cells.
Imataki O; Heike Y; Ishida T; Takaue Y; Ikarashi Y; Yoshida M; Wakasugi H; Kakizoe T
J Immunother; 2006; 29(3):320-7. PubMed ID: 16699375
[TBL] [Abstract][Full Text] [Related]
14. [Proliferation of natural killer T cells in umbilical cord blood and peripheral blood and their different phenotypes].
Liu Y; Fan HH; Ruan M; Gao L; Nie XX; Yang YM; Lu HZ; Gao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):128-32. PubMed ID: 16584608
[TBL] [Abstract][Full Text] [Related]
15. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
van der Vliet HJ ; Nishi N; Koezuka Y; von Blomberg BM ; van den Eertwegh AJ ; Porcelli SA; Pinedo HM; Scheper RJ; Giaccone G
J Immunol Methods; 2001 Jan; 247(1-2):61-72. PubMed ID: 11150537
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
17. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells.
Kenna T; Golden-Mason L; Porcelli SA; Koezuka Y; Hegarty JE; O'Farrelly C; Doherty DG
J Immunol; 2003 Aug; 171(4):1775-9. PubMed ID: 12902477
[TBL] [Abstract][Full Text] [Related]
18. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
[TBL] [Abstract][Full Text] [Related]
19. Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients.
Motohashi S; Kobayashi S; Ito T; Magara KK; Mikuni O; Kamada N; Iizasa T; Nakayama T; Fujisawa T; Taniguchi M
Int J Cancer; 2002 Nov; 102(2):159-65. PubMed ID: 12385012
[TBL] [Abstract][Full Text] [Related]
20. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
Rogers PR; Matsumoto A; Naidenko O; Kronenberg M; Mikayama T; Kato S
J Immunol Methods; 2004 Feb; 285(2):197-214. PubMed ID: 14980434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
